biotech · SCNI
Scinai Immunotherapeutics
News and analysis for Scinai Immunotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
JERUSALEM, L3, USA HQ
Public company Type
SCNI · NYSE Ticker
Company details
- Status
- Public
- HQ
- JERUSALEM, L3, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Scinai Immunotherapeutics — regulatory, clinical, and market coverage.
News and analysis for Scinai Immunotherapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.